Javascript must be enabled to continue!
Survival between synchronous and non-synchronous multiple primary cutaneous melanomas—a SEER database analysis
View through CrossRef
Background
There is no criterion to distinguish synchronous and non-synchronous multiple primary cutaneous melanomas (MPMs). This study aimed to distinguish synchronous and non-synchronous MPMs and compare the survivals of them using the Surveillance, Epidemiology, and End Results database.
Methods
Synchronous and non-synchronous MPMs were distinguished by fitting the double log transformed distribution of the time interval between the first and second primary cutaneous melanomas (TIFtS) through a piecewise linear regression. The overall and melanoma-specific survivals were compared by the Kaplan–Meier method and Cox proportional hazard model through modeling the occurrence of synchronous MPMs as a time-dependent variable.
Results
The distribution of TIFtS was composed by three power-law distributions. According to its first inflection point, synchronous MPMs were defined as tumors that occurred within 2 months. The Kaplain–Meier plot revealed a significant inferior survival for synchronous MPMs than non-synchronous MPMs (P < 0.0001), and the occurrence of synchronous MPM was a risk factor for overall survival of cutaneous melanoma (CM) (hazard ratio: 2.213; (95% CI [2.087–2.346]); P < 0.0001).
Conclusions
This study provided data analysis evidences for using 2 months to distinguish synchronous MPMs and non-synchronous MPMs. Furthermore, the occurrence of synchronous MPM was a risk factor for prognosis of patients with CM.
Title: Survival between synchronous and non-synchronous multiple primary cutaneous melanomas—a SEER database analysis
Description:
Background
There is no criterion to distinguish synchronous and non-synchronous multiple primary cutaneous melanomas (MPMs).
This study aimed to distinguish synchronous and non-synchronous MPMs and compare the survivals of them using the Surveillance, Epidemiology, and End Results database.
Methods
Synchronous and non-synchronous MPMs were distinguished by fitting the double log transformed distribution of the time interval between the first and second primary cutaneous melanomas (TIFtS) through a piecewise linear regression.
The overall and melanoma-specific survivals were compared by the Kaplan–Meier method and Cox proportional hazard model through modeling the occurrence of synchronous MPMs as a time-dependent variable.
Results
The distribution of TIFtS was composed by three power-law distributions.
According to its first inflection point, synchronous MPMs were defined as tumors that occurred within 2 months.
The Kaplain–Meier plot revealed a significant inferior survival for synchronous MPMs than non-synchronous MPMs (P < 0.
0001), and the occurrence of synchronous MPM was a risk factor for overall survival of cutaneous melanoma (CM) (hazard ratio: 2.
213; (95% CI [2.
087–2.
346]); P < 0.
0001).
Conclusions
This study provided data analysis evidences for using 2 months to distinguish synchronous MPMs and non-synchronous MPMs.
Furthermore, the occurrence of synchronous MPM was a risk factor for prognosis of patients with CM.
Related Results
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Background Cutaneous involvement is very common in systemic lupus erythematosus. We describe the prevalence and spectrum of lupus-specific (cutaneous lupus erythematosus) and non-s...
High Expression of AMIGO2 Is an Independent Predictor of Poor Prognosis in Pancreatic Cancer
High Expression of AMIGO2 Is an Independent Predictor of Poor Prognosis in Pancreatic Cancer
Abstract
Background.The AMIGO2 extracellular domain has a leucine - rich repetitive domain (LRR) and encodes a type 1 transmembrane protein , and is a member of the AMIGO g...
Trends in survival, mortality determinants, and demographic factors in pancreatic carcinoma: An analysis from 2000 to 2021.
Trends in survival, mortality determinants, and demographic factors in pancreatic carcinoma: An analysis from 2000 to 2021.
e16434
Background:
Pancreatic carcinoma is among the deadliest malignancies, with persistently low survival rates and significant disp...
Why do melanomas ulcerate?
Why do melanomas ulcerate?
Ulceration is an indicator of unfavourable prognosis in malignant melanoma (MM). But why do melanomas ulcerate?. Possible causes of ulecration were investigated in a group of 69 ul...
Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival
Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival
AbstractWhile only 15–25 percent of melanoma patients develop distant metastasis and die, this disease is still responsible for the majority of skin cancer-related deaths. The avai...
Treatment of Patient with Cutaneous Lupus Erythematosus with Roflumilast Cream 0.3%
Treatment of Patient with Cutaneous Lupus Erythematosus with Roflumilast Cream 0.3%
Introduction: Cutaneous lupus erythematosus (CLE) is the cutaneous form of a common autoimmune disease, lupus erythematosus, driven by a dysfunction within the adaptive and innate ...
Cutaneous arteriolitis: A novel cutaneous small vessel vasculitis disorder clinicopathologically different from cutaneous polyarteritis nodosa and cutaneous venulitis
Cutaneous arteriolitis: A novel cutaneous small vessel vasculitis disorder clinicopathologically different from cutaneous polyarteritis nodosa and cutaneous venulitis
AbstractCutaneous vasculitis can be classified into two types based on the affected vessel size: small vessel vasculitis predominantly affecting dermal venules, and muscular vessel...
Hairy Cell Leukemia – A Mortality Analysis
Hairy Cell Leukemia – A Mortality Analysis
Objectives.—To assess mortality and survival analysis for patients with hairy cell leukemia, taking into consideration the effect of new therapies.
Background.—H...


